Gaetano Giuffrida

1.0k total citations
42 papers, 529 citations indexed

About

Gaetano Giuffrida is a scholar working on Hematology, Physiology and Cell Biology. According to data from OpenAlex, Gaetano Giuffrida has authored 42 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 13 papers in Physiology and 9 papers in Cell Biology. Recurrent topics in Gaetano Giuffrida's work include Lysosomal Storage Disorders Research (13 papers), Platelet Disorders and Treatments (11 papers) and Cellular transport and secretion (9 papers). Gaetano Giuffrida is often cited by papers focused on Lysosomal Storage Disorders Research (13 papers), Platelet Disorders and Treatments (11 papers) and Cellular transport and secretion (9 papers). Gaetano Giuffrida collaborates with scholars based in Italy, United States and Slovenia. Gaetano Giuffrida's co-authors include Samo Zver, Fabrizio Fabris, Pier Mannuccio Mannucci, Maria Teresa Canciani, Silvia Lavoretano, Flora Peyvandi, Tullia Battaglioli, Carla Valsecchi, Karen Vanhoorelbeke and Mehran Karimi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Gaetano Giuffrida

38 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaetano Giuffrida Italy 11 245 216 155 116 102 42 529
Iain Moore United Kingdom 10 283 1.2× 500 2.3× 71 0.5× 375 3.2× 41 0.4× 14 626
Norihiro Iwamoto Japan 12 141 0.6× 291 1.3× 74 0.5× 138 1.2× 39 0.4× 26 463
Juri Alessandro Giannotta Italy 14 388 1.6× 133 0.6× 156 1.0× 18 0.2× 236 2.3× 45 565
Oliver Amon Germany 8 121 0.5× 264 1.2× 44 0.3× 137 1.2× 229 2.2× 17 543
Idris Boudhabhay France 9 92 0.4× 107 0.5× 105 0.7× 76 0.7× 47 0.5× 30 298
Constance Guillaud France 8 274 1.1× 68 0.3× 179 1.2× 21 0.2× 157 1.5× 18 525
Scott C. Meixner Canada 8 143 0.6× 136 0.6× 38 0.2× 31 0.3× 38 0.4× 12 381
Soracha E. Ward Ireland 11 279 1.1× 116 0.5× 72 0.5× 12 0.1× 21 0.2× 17 560
Tina Dutt United Kingdom 11 148 0.6× 268 1.2× 92 0.6× 139 1.2× 10 0.1× 31 382

Countries citing papers authored by Gaetano Giuffrida

Since Specialization
Citations

This map shows the geographic impact of Gaetano Giuffrida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaetano Giuffrida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaetano Giuffrida more than expected).

Fields of papers citing papers by Gaetano Giuffrida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaetano Giuffrida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaetano Giuffrida. The network helps show where Gaetano Giuffrida may publish in the future.

Co-authorship network of co-authors of Gaetano Giuffrida

This figure shows the co-authorship network connecting the top 25 collaborators of Gaetano Giuffrida. A scholar is included among the top collaborators of Gaetano Giuffrida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaetano Giuffrida. Gaetano Giuffrida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marano, Massimo, Immacolata Tartaglione, Marco Spada, et al.. (2025). Identification of Novel Mutations in Patients Affected by Gaucher Disease. International Journal of Molecular Sciences. 26(8). 3918–3918.
2.
Olimpieri, Pier Paolo, Gaetano Giuffrida, Edoardo Milanetti, et al.. (2025). Vitamin K Antagonists (VKAs) and Novel Oral Anticoagulants (NOACs) Safety Comparison Based on Data from EudraVigilance Database. Hematology Reports. 17(5). 54–54.
3.
Fianchi, Luana, Alessandra Borchiellini, Gaetano Giuffrida, et al.. (2024). Real-World Data on Effectiveness and Safety of First-Line Use of Caplacizumab in Italian Centers for the Treatment of Thrombotic Thrombocytopenic Purpura: The Roscapli Study. Journal of Clinical Medicine. 13(21). 6561–6561.
4.
Colomba, Paolo, Giovanni Caocci, Gaetano Giuffrida, et al.. (2024). Gaucher Disease or Acid Sphingomyelinase Deficiency? The Importance of Differential Diagnosis. Journal of Clinical Medicine. 13(5). 1487–1487. 2 indexed citations
5.
Pennisi, Maria Stella, Sandra Di Gregorio, Elena Tirrò, et al.. (2023). Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports. SHILAP Revista de lepidopterología. 15(2). 317–324. 1 indexed citations
6.
Duminuco, Andrea, L. Gullo, Valeria Calafiore, et al.. (2023). Effectiveness and Safety of Eliglustat Treatment in Gaucher Disease: Real-life Unicentric Experience. Clinical Therapeutics. 45(11). 1105–1110. 3 indexed citations
7.
Cappellini, Maria Domenica, Irene Motta, Antonio Barbato, et al.. (2022). Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis. European Journal of Internal Medicine. 108. 81–84. 5 indexed citations
8.
Cortesi, Paolo Angelo, Giovanni Di Minno, Ezio Zanon, et al.. (2022). Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973). Journal of Clinical Medicine. 11(12). 3434–3434. 2 indexed citations
9.
Cappellini, Maria Domenica, Francesca Carubbi, Maja Di Rocco, Fiorina Giona, & Gaetano Giuffrida. (2022). Long-term bone outcomes in Italian patients with Gaucher disease type 1 or type 3 treated with imiglucerase: A sub-study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry. Blood Cells Molecules and Diseases. 98. 102705–102705. 8 indexed citations
10.
Duminuco, Andrea, et al.. (2022). Acquired hemophilia A following COVID-19 vaccination – The importance of prompt diagnosis: A case report. Transfusion and Apheresis Science. 62(2). 103577–103577. 5 indexed citations
11.
Vianelli, Nicola, Giuseppe Auteri, Francesco Buccisano, et al.. (2022). Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives. Annals of Hematology. 101(5). 963–978. 31 indexed citations
12.
Tiscia, Giovanni Luca, Maria Teresa Sartori, Gaetano Giuffrida, et al.. (2021). Focus on Key Issues in Immune Thrombotic Thrombocytopenic Purpura: Italian Experience of Six Centers. Journal of Clinical Medicine. 10(23). 5702–5702. 1 indexed citations
13.
Giuffrida, Gaetano, et al.. (2021). Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine. Haematologica. 107(4). 1008–1010. 13 indexed citations
14.
Markovic, Uroš, et al.. (2021). Immune thrombocytopenic purpura cases following COVID-19 vaccination.. Mediterranean Journal of Hematology and Infectious Diseases. 13(1). e2021047–e2021047. 7 indexed citations
15.
Rocco, Maja Di, Alessio Di Fonzo, Antonio Barbato, et al.. (2020). Parkinson’s disease in Gaucher disease patients: what’s changing in the counseling and management of patients and their relatives?. Orphanet Journal of Rare Diseases. 15(1). 262–262. 5 indexed citations
16.
Giuffrida, Gaetano, et al.. (2020). A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents. SHILAP Revista de lepidopterología. 9(2). 623–628. 2 indexed citations
17.
Santoro, Rita, et al.. (2020). Tailoring haemophilia A prophylaxis with BAY 81-8973: A case series. Transfusion and Apheresis Science. 59(6). 102897–102897. 3 indexed citations
18.
Giuffrida, Gaetano, Maria Domenica Cappellini, Francesca Carubbi, Maja Di Rocco, & Giovanni Iolascon. (2014). Management of Bone Disease in Gaucher Disease Type 1: Clinical Practice. Advances in Therapy. 31(12). 1197–1212. 28 indexed citations
19.
Rocco, Maja Di, Generoso Andria, Bruno Bembi, et al.. (2012). Minimal disease activity in Gaucher disease: Criteria for definition. Molecular Genetics and Metabolism. 107(3). 521–525. 4 indexed citations
20.
Peyvandi, Flora, Silvia Lavoretano, Roberta Palla, et al.. (2008). ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica. 93(2). 232–239. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iain Moore Breakdown of academic impact, for papers by Norihiro Iwamoto Breakdown of academic impact, for papers by Juri Alessandro Giannotta Breakdown of academic impact, for papers by Oliver Amon Breakdown of academic impact, for papers by Idris Boudhabhay Breakdown of academic impact, for papers by Constance Guillaud Breakdown of academic impact, for papers by Scott C. Meixner Breakdown of academic impact, for papers by Soracha E. Ward Breakdown of academic impact, for papers by Tina Dutt
Rankless by CCL
2026